source
- Cancer cases weigh down Abivax’s Phase 3 maintenance data in ulcerative colitisAbivax has proclaimed that its maintenance trial in ulcerative colitis delivered “landmark” results, and the drug's safety profile has previously been one of its main potential selling points. But…Endpoints · 2mo ago↗ source
- Praxis sinks on late-stage study fail for seizure pill, halts second trialPraxis Precision Medicines has had a decent run over the past eight months or so, with two major clinical wins. But on Monday, the company disclosed a late-stage failure for its investigational sei…Endpoints · 2mo ago↗ source
- ASCO ‘26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancerAt the year’s biggest cancer meeting, a high-stakes clash between two popular drug classes erupted, and scientists made headway against a once-insurmountable foe.